TD Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-40,800
| Closed | -$144K | – | 1418 |
|
2015
Q4 | $144K | Sell |
40,800
-2,100
| -5% | -$7.41K | ﹤0.01% | 1330 |
|
2015
Q3 | $216K | Hold |
42,900
| – | – | ﹤0.01% | 1286 |
|
2015
Q2 | $276K | Sell |
42,900
-10,239
| -19% | -$65.9K | ﹤0.01% | 1279 |
|
2015
Q1 | $374K | Sell |
53,139
-11,681
| -18% | -$82.2K | ﹤0.01% | 1183 |
|
2014
Q4 | $499K | Buy |
64,820
+9,428
| +17% | +$72.6K | ﹤0.01% | 1097 |
|
2014
Q3 | $413K | Buy |
55,392
+15,892
| +40% | +$118K | ﹤0.01% | 1078 |
|
2014
Q2 | $382K | Hold |
39,500
| – | – | ﹤0.01% | 1101 |
|
2014
Q1 | $328K | Hold |
39,500
| – | – | ﹤0.01% | 1136 |
|
2013
Q4 | $333K | Hold |
39,500
| – | – | ﹤0.01% | 1124 |
|
2013
Q3 | $315K | Sell |
39,500
-700
| -2% | -$5.58K | ﹤0.01% | 1095 |
|
2013
Q2 | $310K | Buy |
+40,200
| New | +$310K | ﹤0.01% | 1036 |
|